Great Information, Real Community, Better Living.
 Main Page
 MedTech News
Tech & Innovation
Living With a Device
 Education Center
Diagnostic Tests
Women's Health
Online Resources
Video Library
Dr. Christopher Kwolek  MedTech  Hero™
Dr. Christopher Kwolek:
Pioneering New Blood Clot Treatments.
About Heroes
 Join the Discussion in  Our Forums
MedTech1 Forums
 Advocacy Center
Contact Congress
Find a Patient Group
 Bookmark Us
Search the Body1 Network
April 10, 2021  
MEDTECH NEWS: Living With a Device

  • Print this Article
  • Email this Article
  • Links/Reprints
  • New Drug Seems to Help Child Autism

    New Drug Seems to Help Child Autism

    July 31, 2002

    (AP) - A newer drug used to treat adults with schizophrenia also curtails serious behavioral problems in children with autism, a study shows.

    Older medications used to treat troublesome conduct can have severe side effects. The research reported in Thursday's New England Journal of Medicine is the first large, controlled study in autistic children of a newer type of antipsychotic drug with fewer adverse reactions.

    The drug, Risperdal, was tested in 101 children with autism who had aggressive behavior, temper tantrums or hurt themselves. Sixty-nine percent of the children who took Risperdal showed a positive response by the end of the eight-week test, compared to 12 percent of the children who were given a dummy pill.

    The drug, also known as risperidone, continued to be effective for six months in most of the children who benefited, said Lawrence Scahill of the Yale Child Study Center, the lead author of the study done in five cities.

    The government-funded research confirmed the results of smaller tests in children, and Scahill said doctors already use Risperdal for behaviorial problems in children with autism, a brain disorder which impairs development.

    "We feel this ought to help people decide for whom it is likely to be helpful, at what dose, and what they can expect in terms of side effects," he said.

    The researchers said Risperdal didn't cause the neurological side effects associated with older drugs, such as awkward movements, stiffening of muscles and restlessness. Those in the Risperdal group did have an average weight gain of 6 pounds. Other mild reactions were fatigue, drowsiness, dizziness and drooling.

    Dr. Isabelle Rapin of Albert Einstein College of Medicine in New York said the results are encouraging and should be followed by larger, longer studies of treatments for autism. "Such studies are sorely needed," she wrote in a commentary in the journal.


    On the Net:

    New England Journal:

    National Institute of Mental Health:

    Last updated: 31-Jul-02

    Interact on Medtech1
    Ask a question or share your opinions on this topic with others in the Body1 community.

    Ovarian Transplant Recipient Pregnant

    Coil Treatment Studied for Aneurysms

    Dr.: Surgery Allowed Woman to Walk

    New Drug Seems to Help Child Autism

    Drugs Restoring Eyesight in Seniors

    Next 5 Features ...

    More Stories ...

    Home About Us Press Jobs Advertise With Us Contact Us
    © 2021 Body1 All rights reserved.
    Disclaimer: The information provided within this website is for educational purposes only and is not a substitute for consultation with your physician or healthcare provider. The opinions expressed herein are not necessarily those of the Owners and Sponsors of this site. By using this site you agree to indemnify, and hold the Owners and Sponsors harmless, from any disputes arising from content posted here-in.